Seher Yaylacı
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Seher Yaylacı has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Demet Kaçaroğlu
Lokman Hekim University, Faculty of Medicine, Department of Medical Biology
7 shared publications - Mustafa O. Guler
The Pritzker School of Molecular Engineering, The University of Chicago, 5640 S. Ellis Ave, Chicago, IL 60637, USA
5 shared publications - Alper Murat Ulasli
Department of Interdisciplinary Stem Cell and Regenerative Medicine, Stem Cell Institute, Ankara University
4 shared publications - Ayse Begum Tekinay
Institute of Materials Science and Nanotechnology, National Nanotechnology Research Center (UNAM), Bilkent University, 06800 Ankara, Turkey
4 shared publications Demet Kaçaroğlu
Medical Biology Department, Faculty of Medicine, Lokman Hekim University, Ankara, Turkey
3 shared publicationsHakan Ceylan
Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine and Sciences, Mayo Clinic, Arizona, USA
3 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by Trakya University in Trakya University Journal of Natural Sciences
- No. Advanced O
HAVDI peptide signaling modulates EMT- and tissue remodeling-related programs in adipose-derived mesenchymal stem cells
Background: The use of biomimetic peptide hydrogels represents an effective strategy to enhance the regenerative properties of adipose-derived mesenchymal stem cells (ADMSCs). The HAVDI peptide sequence, derived from the N-cadherin protein, has been shown to promote mesenchymal stem cell (MSC) proliferation and chondrogenic differentiation. Aims: In this study, we aimed to investigate the effects of an N-cadherin-mimetic microenvironment on stemness-associated features, tissue remodelling, and epithelial-mesenchymal transition (EMT)-related gene expression in ADMSCs. Methods: A two-dimensional culture environment was established using standard tissue culture plates, HAVDI-coated surfaces, and scrambled HAVDI control coatings. TLR4 activation experiments were performed using lipopolysaccharide (LPS) treatment (0.1 μg/mL for 48 h), either alone or in combination with HAVDI or SCRAM peptides. Gene expression profiles were analysed by quantitative real-time PCR, while mesenchymal stem cell surface markers (CD90, CD73, and CD105) were evaluated by flow cytometry. Immunofluorescence staining was performed for E-cadherin and vimentin, and a colony formation assay was conducted.Results: Compared with the tissue culture plate control group, the HAVDI group exhibited increased surface marker expression, with increases of 9% for CD90⁺, 8.2% for CD73⁺, and 9.2% for CD105⁺ cells. Moreover, EMT- and tissue remodelling-associated genes, including CD44, VIM, ZEB1, CDH1, MMP9, TIMP1, and CLDN1, were significantly upregulated in the HAVDI group. Compared to the TC PLATE group, the HAVDI group showed a significant increase in colony formation. TLR4 activation attenuated HAVDI-associated changes in the expression of EMT- and tissue remodelling-related genes in ADMSCs.Conclusion: Overall, the HAVDI biomimetic environment promoted stemness-associated features and modulated EMT- and tissue remodelling-related profiles in ADMSCs. Concurrent epithelial and mesenchymal marker changes suggest a context-dependent phenotype rather than classical EMT, supporting the potential of HAVDI-based platforms for regenerative applications.
- 11 November 2026
- Published by Trakya University in Trakya University Journal of Natural Sciences
- No. Advanced O
Open AccessHAVDI peptide signaling modulates EMT- and tissue remodeling-related programs in adipose-derived mesenchymal stem cells
Background: The use of biomimetic peptide hydrogels represents an effective strategy to enhance the regenerative properties of adipose-derived mesenchymal stem cells (ADMSCs). The HAVDI peptide sequence, derived from the N-cadherin protein, has been shown to promote mesenchymal stem cell (MSC) proliferation and chondrogenic differentiation. Aims: In this study, we aimed to investigate the effects of an N-cadherin-mimetic microenvironment on stemness-associated features, tissue remodelling, and epithelial-mesenchymal transition (EMT)-related gene expression in ADMSCs. Methods: A two-dimensional culture environment was established using standard tissue culture plates, HAVDI-coated surfaces, and scrambled HAVDI control coatings. TLR4 activation experiments were performed using lipopolysaccharide (LPS) treatment (0.1 μg/mL for 48 h), either alone or in combination with HAVDI or SCRAM peptides. Gene expression profiles were analysed by quantitative real-time PCR, while mesenchymal stem cell surface markers (CD90, CD73, and CD105) were evaluated by flow cytometry. Immunofluorescence staining was performed for E-cadherin and vimentin, and a colony formation assay was conducted.Results: Compared with the tissue culture plate control group, the HAVDI group exhibited increased surface marker expression, with increases of 9% for CD90⁺, 8.2% for CD73⁺, and 9.2% for CD105⁺ cells. Moreover, EMT- and tissue remodelling-associated genes, including CD44, VIM, ZEB1, CDH1, MMP9, TIMP1, and CLDN1, were significantly upregulated in the HAVDI group. Compared to the TC PLATE group, the HAVDI group showed a significant increase in colony formation. TLR4 activation attenuated HAVDI-associated changes in the expression of EMT- and tissue remodelling-related genes in ADMSCs.Conclusion: Overall, the HAVDI biomimetic environment promoted stemness-associated features and modulated EMT- and tissue remodelling-related profiles in ADMSCs. Concurrent epithelial and mesenchymal marker changes suggest a context-dependent phenotype rather than classical EMT, supporting the potential of HAVDI-based platforms for regenerative applications.
- Open Access
- 25 June 2026
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 7 (3) , 424-430
Evolution and emerging directions in antimicrobial surface engineering for dental implants: a bibliometric and trend analysis (2015–2025)
Aims: Peri-implantitis and biofilm-associated infections remain major complications compromising the long-term success of dental implants. In response, antimicrobial surface engineering strategies have rapidly expanded over the past decade. However, the scientific evolution, thematic structure, and emerging directions of antimicrobial coatings in dental implant research have not been comprehensively mapped. This study aims to perform a bibliometric analysis of global scientific literature investigating antimicrobial surface engineering approaches for dental implants. Methods: A bibliometric analysis was conducted using VOSviewer software. The Scopus database was searched on February, 2026, using keywords related to “dental implant,” “antimicrobial coating,” and “surface modification,” covering the period between 2015 and 2025. Articles and reviews published in English were included, yielding a total of 447 records. Publication trends, country productivity, citation performance, keyword co-occurrence networks, and temporal evolution of research themes were analyzed. Results: The analysis demonstrated a steady increase in publications, particularly after 2018, reflecting growing scientific interest in antimicrobial implant technologies. China, the United States, and India were among the most productive countries. Research output was distributed across both dental and materials science journals. Keyword co-occurrence analysis identified seven thematic clusters, primarily centered on titanium surface modification, osseointegration, silver nanoparticle-based antimicrobial strategies, biofilm inhibition, and biocompatibility. Overlay visualization revealed a temporal shift from silver-dominant antibacterial approaches toward multifunctional surface engineering strategies emphasizing bioactivity, nanotechnology, and advanced fabrication techniques.Conclusion: This study provides a comprehensive bibliometric mapping of antimicrobial surface engineering research in dental implants. The findings highlight the field’s evolution from simple antibacterial incorporation to integrated biofunctional surface strategies. Despite rapid technological advancement, limited emphasis on long-term clinical outcomes indicates a translational gap. These insights may guide future research directions and strategic development in implant surface engineering.
- 25 June 2026
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 7 (3) , 424-430
Open AccessEvolution and emerging directions in antimicrobial surface engineering for dental implants: a bibliometric and trend analysis (2015–2025)
Aims: Peri-implantitis and biofilm-associated infections remain major complications compromising the long-term success of dental implants. In response, antimicrobial surface engineering strategies have rapidly expanded over the past decade. However, the scientific evolution, thematic structure, and emerging directions of antimicrobial coatings in dental implant research have not been comprehensively mapped. This study aims to perform a bibliometric analysis of global scientific literature investigating antimicrobial surface engineering approaches for dental implants. Methods: A bibliometric analysis was conducted using VOSviewer software. The Scopus database was searched on February, 2026, using keywords related to “dental implant,” “antimicrobial coating,” and “surface modification,” covering the period between 2015 and 2025. Articles and reviews published in English were included, yielding a total of 447 records. Publication trends, country productivity, citation performance, keyword co-occurrence networks, and temporal evolution of research themes were analyzed. Results: The analysis demonstrated a steady increase in publications, particularly after 2018, reflecting growing scientific interest in antimicrobial implant technologies. China, the United States, and India were among the most productive countries. Research output was distributed across both dental and materials science journals. Keyword co-occurrence analysis identified seven thematic clusters, primarily centered on titanium surface modification, osseointegration, silver nanoparticle-based antimicrobial strategies, biofilm inhibition, and biocompatibility. Overlay visualization revealed a temporal shift from silver-dominant antibacterial approaches toward multifunctional surface engineering strategies emphasizing bioactivity, nanotechnology, and advanced fabrication techniques.Conclusion: This study provides a comprehensive bibliometric mapping of antimicrobial surface engineering research in dental implants. The findings highlight the field’s evolution from simple antibacterial incorporation to integrated biofunctional surface strategies. Despite rapid technological advancement, limited emphasis on long-term clinical outcomes indicates a translational gap. These insights may guide future research directions and strategic development in implant surface engineering.
- 30 March 2026
- Published by Kütahya Dumlupinar Üniversitesi in Journal of Scientific Reports-A
- No. 064,p. 1-5
Corrigendum: Inducing chondrogenic differentiation in ATDC5 cells using a three-dimensional hydrogel with GAG-mimicking properties
A Corrigendum onInducing chondrogenic differentiation in ATDC5 cells using a three-dimensional hydrogel with GAG-mimicking properties by S. Yaylacı, JSR-A, no. 058, pp. 1–9, September2024, doi: 10.59313/jsr-a.1439875.In the published version of this article, it was identified that Figure 1c is identical to Figure 1 (b) and (c) from a previously published work by the same author(s) (Biomacromolecules, 2013, 14, 17–26, DOI: https://dx.doi.org/10.1021/bm301538k). This duplication occurred inadvertently due to a file management error. The figure in question depicts the morphological characteristics of peptide amphiphile (PA) nanofibers imaged via scanning electron microscopy (SEM). While the materials used in both studies exhibit similar structural features, inclusion of a previously published figure without explicit citation or justification was inappropriate. To address this error and ensure compliance with ethical publishing standards, a new figure—specific to the current study and derived from original data—has been prepared and submitted to replace the original Figure 1c. Additionally, Figure 2f-g was mistakenly labeled as a hematoxylin and eosin (H&E) stained image, when in fact it is a Safranin-O stained section. This image does not originate from the current study’s dataset and was included in error during file compilation. The figure does not contribute additional scientific value, as the relevant staining data are already correctly represented in Figures 2 and 3. Removal of Figure 2f-g does not affect the scientific integrity or conclusions of the article. We apologize for these errors and for any confusion they may have caused. This correction has been issued to uphold the accuracy and integrity of the scientific record.
- 30 March 2026
- Published by Kütahya Dumlupinar Üniversitesi in Journal of Scientific Reports-A
- No. 064,p. 1-5
Corrigendum: Inducing chondrogenic differentiation in ATDC5 cells using a three-dimensional hydrogel with GAG-mimicking properties
A Corrigendum onInducing chondrogenic differentiation in ATDC5 cells using a three-dimensional hydrogel with GAG-mimicking properties by S. Yaylacı, JSR-A, no. 058, pp. 1–9, September2024, doi: 10.59313/jsr-a.1439875.In the published version of this article, it was identified that Figure 1c is identical to Figure 1 (b) and (c) from a previously published work by the same author(s) (Biomacromolecules, 2013, 14, 17–26, DOI: https://dx.doi.org/10.1021/bm301538k). This duplication occurred inadvertently due to a file management error. The figure in question depicts the morphological characteristics of peptide amphiphile (PA) nanofibers imaged via scanning electron microscopy (SEM). While the materials used in both studies exhibit similar structural features, inclusion of a previously published figure without explicit citation or justification was inappropriate. To address this error and ensure compliance with ethical publishing standards, a new figure—specific to the current study and derived from original data—has been prepared and submitted to replace the original Figure 1c. Additionally, Figure 2f-g was mistakenly labeled as a hematoxylin and eosin (H&E) stained image, when in fact it is a Safranin-O stained section. This image does not originate from the current study’s dataset and was included in error during file compilation. The figure does not contribute additional scientific value, as the relevant staining data are already correctly represented in Figures 2 and 3. Removal of Figure 2f-g does not affect the scientific integrity or conclusions of the article. We apologize for these errors and for any confusion they may have caused. This correction has been issued to uphold the accuracy and integrity of the scientific record.
- 28 March 2026
- Published by SAGE Publications in Journal of Dental Research
- Vol. 105 (12) , 1583-1593
Injectable Nanofiber Gel Enhances Osseointegration in a Rabbit Model
High insertion torque can cause conventional bioactive implant coatings to delaminate, generating debris and compromising osseointegration. We developed and evaluated an injectable, self-assembling peptide nanofiber interface designed to be applied in the osteotomy site to enhance biomechanical stability and accelerate bone formation. A multifunctional, injectable gel was formed from self-assembling peptide amphiphiles designed to be osteoinductive, adhesive, and antimicrobial. In a rabbit model, custom titanium implants were placed with either the nanofiber interface or a standard sand-blasted, large-grit, acid-etched (SLA) surface. Osseointegration was evaluated at 3 and 5 wk using micro–computed tomography (micro-CT) for bone-to-implant contact (BIC) and bone volume/total volume (BV/TV), as well as biomechanical reverse torque testing. At 5 wk, implants with the nanofiber interface demonstrated significantly superior osseointegration. BIC reached 58.7% compared to 50.5% for SLA-treated implants ( P < 0.001). BV/TV was also significantly higher at 51.8% versus 42.6% for the SLA group ( P < 0.001). Crucially, biomechanical stability was markedly improved, with the nanofiber group withstanding a reverse torque of 53.2 N·cm, significantly higher than the 41.8 N·cm for the SLA group ( P < 0.01). This injectable nanofiber interface successfully overcomes the limitations of traditional coatings by enhancing bone–implant integration and providing superior biomechanical stability. Uniquely, it is designed to prevent or repair drilling-induced microdamage, occupy peri-implant microcracks with a structural nanoscaffold, and act as a flowable, conformal osteotomy liner when applied prior to implant insertion. This practical approach represents a promising strategy to improve long-term clinical outcomes, particularly in patients with compromised bone quality or a higher risk of implant failure.
- 28 March 2026
- Published by SAGE Publications in Journal of Dental Research
- Vol. 105 (12) , 1583-1593
Injectable Nanofiber Gel Enhances Osseointegration in a Rabbit Model
High insertion torque can cause conventional bioactive implant coatings to delaminate, generating debris and compromising osseointegration. We developed and evaluated an injectable, self-assembling peptide nanofiber interface designed to be applied in the osteotomy site to enhance biomechanical stability and accelerate bone formation. A multifunctional, injectable gel was formed from self-assembling peptide amphiphiles designed to be osteoinductive, adhesive, and antimicrobial. In a rabbit model, custom titanium implants were placed with either the nanofiber interface or a standard sand-blasted, large-grit, acid-etched (SLA) surface. Osseointegration was evaluated at 3 and 5 wk using micro–computed tomography (micro-CT) for bone-to-implant contact (BIC) and bone volume/total volume (BV/TV), as well as biomechanical reverse torque testing. At 5 wk, implants with the nanofiber interface demonstrated significantly superior osseointegration. BIC reached 58.7% compared to 50.5% for SLA-treated implants ( P < 0.001). BV/TV was also significantly higher at 51.8% versus 42.6% for the SLA group ( P < 0.001). Crucially, biomechanical stability was markedly improved, with the nanofiber group withstanding a reverse torque of 53.2 N·cm, significantly higher than the 41.8 N·cm for the SLA group ( P < 0.01). This injectable nanofiber interface successfully overcomes the limitations of traditional coatings by enhancing bone–implant integration and providing superior biomechanical stability. Uniquely, it is designed to prevent or repair drilling-induced microdamage, occupy peri-implant microcracks with a structural nanoscaffold, and act as a flowable, conformal osteotomy liner when applied prior to implant insertion. This practical approach represents a promising strategy to improve long-term clinical outcomes, particularly in patients with compromised bone quality or a higher risk of implant failure.
- Open Access
- 31 December 2025
- Published by Istanbul Gelisim University in İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi
- No. 27,p. 824-836
Exploring the Effects of WJ-MSC-Derived Exosomes on the Viability and Metabolic Activity of Lung, Pancreatic and Liver Cancer Cells
Aim: Mesenchymal stem cells (MSCs) act on cancer cells in the same microenvironment by secreting cytokines, chemokines, exosomes, or by direct contact. The purpose of this study is to analyse the impact of WJ-MSC-derived exosomes on the viability and metabolic activity of lung, pancreatic, and liver cancer cells. Method: In this study, Wharton's Jelly (WJ)-MSCs-derived exosomes were added to A549, Panc-1, and HepG2 cells as 1-5-10-15 and 20 million particle exosomes. The effects on viability were evaluated by MTT analysis at 48 and 96 hours. The effects on metabolic activity were evaluated by calcein staining at the end of the 96th hour. Cell metabolic activity was calculated using fluorescence intensity. Results: At the end of the 96th hour, 62% increase in A549 cells, 95% increase in Panc-1 cells and 67% increase in HepG2 cells were detected in the control group. In the group which 20 million exosomes were applied, 36% increase in A549 cells, 43% increase in Panc-1 cells and 31% increase in HepG2 cells were observed. The fluorescence intensity of 20 million exosomes was calculated as: A549: 61%, Panc-1: 64% and HepG2: 68%. Preliminary findings indicate that WJ-MSC-derived exosomes do not increase the viability and metabolic activity of cancer cells when applied to them. It was also shown that the viability and metabolic activity can decrease depending on time and concentration. Conclusion: WJ-MSC-derived exosomes may be effective on cell viability and metabolic activity in vitro in tumors with high stroma content, and their effects on other mechanisms on tumor cells need to be investigated.
- 31 December 2025
- Published by Istanbul Gelisim University in İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi
- No. 27,p. 824-836
Open AccessExploring the Effects of WJ-MSC-Derived Exosomes on the Viability and Metabolic Activity of Lung, Pancreatic and Liver Cancer Cells
Aim: Mesenchymal stem cells (MSCs) act on cancer cells in the same microenvironment by secreting cytokines, chemokines, exosomes, or by direct contact. The purpose of this study is to analyse the impact of WJ-MSC-derived exosomes on the viability and metabolic activity of lung, pancreatic, and liver cancer cells. Method: In this study, Wharton's Jelly (WJ)-MSCs-derived exosomes were added to A549, Panc-1, and HepG2 cells as 1-5-10-15 and 20 million particle exosomes. The effects on viability were evaluated by MTT analysis at 48 and 96 hours. The effects on metabolic activity were evaluated by calcein staining at the end of the 96th hour. Cell metabolic activity was calculated using fluorescence intensity. Results: At the end of the 96th hour, 62% increase in A549 cells, 95% increase in Panc-1 cells and 67% increase in HepG2 cells were detected in the control group. In the group which 20 million exosomes were applied, 36% increase in A549 cells, 43% increase in Panc-1 cells and 31% increase in HepG2 cells were observed. The fluorescence intensity of 20 million exosomes was calculated as: A549: 61%, Panc-1: 64% and HepG2: 68%. Preliminary findings indicate that WJ-MSC-derived exosomes do not increase the viability and metabolic activity of cancer cells when applied to them. It was also shown that the viability and metabolic activity can decrease depending on time and concentration. Conclusion: WJ-MSC-derived exosomes may be effective on cell viability and metabolic activity in vitro in tumors with high stroma content, and their effects on other mechanisms on tumor cells need to be investigated.
- Open Access
- 27 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-17
Multifunctional peptide nanofiber coatings enhance bone regeneration on xenograft materials
Conventional bone grafts such as xenografts, allografts, and synthetic substitutes are widely used in regenerative dentistry, but their biological performance remains suboptimal. To address this limitation, this study investigates the effect of multifunctional peptide amphiphile (PA) nanofiber coatings on graft bioactivity. Peptide amphiphile molecules incorporating osteoinductive (DGEA-PA), mineralization-promoting (EEE-PA), adhesive (DOPA-PA), and antimicrobial (GL13K-PA) sequences were synthesized via Fmoc-based solid-phase peptide synthesis. The combined PA formulation was self-assembled into nanofibers and used to functionalize xenograft, allograft, and synthetic hydroxyapatite-based grafts. In vitro assays with human dental pulp stem cells (DPSCs) assessed adhesion, viability, osteogenic gene expression, alkaline phosphatase (ALP) activity, and mineralization. In vivo performance was evaluated in a rabbit calvarial critical-sized defect model using micro-CT and histology. Peptide-coated grafts significantly enhanced early cell adhesion and proliferation compared to unmodified controls. qRT-PCR revealed upregulation of osteogenesis-related genes (RUNX2, OPN, COL1A1), especially in peptide-treated groups. ALP activity and calcium deposition were markedly increased on PA-functionalized grafts. In vivo, micro-CT and histological analysis demonstrated greater bone volume, trabecular maturation, and integration in peptide-treated defects, particularly in the PA nanofiber-only and peptide-coated xenograft groups. Functionalization of conventional bone grafts with a tailored peptide amphiphile nanofiber mixture improves cellular response, osteogenic differentiation, and bone regeneration. This strategy offers a minimally invasive and translationally relevant approach for enhancing graft biofunctionality in bone repair applications.
- 27 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-17
Open AccessMultifunctional peptide nanofiber coatings enhance bone regeneration on xenograft materials
Conventional bone grafts such as xenografts, allografts, and synthetic substitutes are widely used in regenerative dentistry, but their biological performance remains suboptimal. To address this limitation, this study investigates the effect of multifunctional peptide amphiphile (PA) nanofiber coatings on graft bioactivity. Peptide amphiphile molecules incorporating osteoinductive (DGEA-PA), mineralization-promoting (EEE-PA), adhesive (DOPA-PA), and antimicrobial (GL13K-PA) sequences were synthesized via Fmoc-based solid-phase peptide synthesis. The combined PA formulation was self-assembled into nanofibers and used to functionalize xenograft, allograft, and synthetic hydroxyapatite-based grafts. In vitro assays with human dental pulp stem cells (DPSCs) assessed adhesion, viability, osteogenic gene expression, alkaline phosphatase (ALP) activity, and mineralization. In vivo performance was evaluated in a rabbit calvarial critical-sized defect model using micro-CT and histology. Peptide-coated grafts significantly enhanced early cell adhesion and proliferation compared to unmodified controls. qRT-PCR revealed upregulation of osteogenesis-related genes (RUNX2, OPN, COL1A1), especially in peptide-treated groups. ALP activity and calcium deposition were markedly increased on PA-functionalized grafts. In vivo, micro-CT and histological analysis demonstrated greater bone volume, trabecular maturation, and integration in peptide-treated defects, particularly in the PA nanofiber-only and peptide-coated xenograft groups. Functionalization of conventional bone grafts with a tailored peptide amphiphile nanofiber mixture improves cellular response, osteogenic differentiation, and bone regeneration. This strategy offers a minimally invasive and translationally relevant approach for enhancing graft biofunctionality in bone repair applications.
- 26 July 2025
- Published by Springer Nature
- p. 31-44
Exploring the Complexities of Bone Implants and Stents: Factors Influencing Successful Tissue Integration
Bone implants and stents are medical devices that are commonly used to treat bone and cardiovascular diseases, respectively. Both require successful integration with the surrounding tissue to achieve long-term success. Osteointegration, the process by which the implant becomes integrated with the surrounding bone, is critical to the success of bone implants, while the stent healing process involves endothelialization, re-endothelialization, and neointimal formation. The healing process of bone is complex and influenced by various factors, including the properties of the implant material, the surgical technique, and patient factors such as age and overall health. Several materials have been developed for bone implants, including metals, ceramics, and polymers. The choice of material depends on the specific application, as each material has unique properties that affect its suitability for a particular use. For example, titanium is commonly used in orthopedic implants due to its biocompatibility, strength, and ability to promote osteointegration. The healing process of stents is influenced by the materials used and the stent design. Drug-eluting stents, which release drugs to reduce restenosis, have been developed to improve the healing process. Endothelialization, the formation of a layer of endothelial cells over the stent, is critical to the prevention of restenosis. Neointimal formation, the formation of new tissue over the stent, can cause restenosis and has been a major concern with bare-metal stents. Factors that affect osteointegration and stent healing process include implant surface properties, such as roughness and topography, as well as the size, shape, and placement of the implant. In addition, patient factors such as age, overall health, and medication use can also affect the healing process. In conclusion, successful integration with the surrounding tissue is critical to the long-term success of bone implants and stents. The choice of implant material, surgical technique, and patient factors all play a role in the healing process, and ongoing research is needed to improve the design and performance of these medical devices.
- 26 July 2025
- Published by Springer Nature
- p. 31-44
Exploring the Complexities of Bone Implants and Stents: Factors Influencing Successful Tissue Integration
Bone implants and stents are medical devices that are commonly used to treat bone and cardiovascular diseases, respectively. Both require successful integration with the surrounding tissue to achieve long-term success. Osteointegration, the process by which the implant becomes integrated with the surrounding bone, is critical to the success of bone implants, while the stent healing process involves endothelialization, re-endothelialization, and neointimal formation. The healing process of bone is complex and influenced by various factors, including the properties of the implant material, the surgical technique, and patient factors such as age and overall health. Several materials have been developed for bone implants, including metals, ceramics, and polymers. The choice of material depends on the specific application, as each material has unique properties that affect its suitability for a particular use. For example, titanium is commonly used in orthopedic implants due to its biocompatibility, strength, and ability to promote osteointegration. The healing process of stents is influenced by the materials used and the stent design. Drug-eluting stents, which release drugs to reduce restenosis, have been developed to improve the healing process. Endothelialization, the formation of a layer of endothelial cells over the stent, is critical to the prevention of restenosis. Neointimal formation, the formation of new tissue over the stent, can cause restenosis and has been a major concern with bare-metal stents. Factors that affect osteointegration and stent healing process include implant surface properties, such as roughness and topography, as well as the size, shape, and placement of the implant. In addition, patient factors such as age, overall health, and medication use can also affect the healing process. In conclusion, successful integration with the surrounding tissue is critical to the long-term success of bone implants and stents. The choice of implant material, surgical technique, and patient factors all play a role in the healing process, and ongoing research is needed to improve the design and performance of these medical devices.
- 26 July 2025
- Published by Springer Nature
- p. 71-86
Sustained Drug Delivery Systems for Age-Related Macular Degeneration: Advancements, Challenges, and Future Perspectives
Age-related macular degeneration (AMD) is a leading cause of vision loss among the elderly and remains a major public health challenge due to its chronic progression and high recurrence rate. Current standard treatment relies heavily on repeated intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents, which impose significant burdens on patients and healthcare systems. In recent years, sustained-release drug delivery systems (SR-DDS) have emerged as promising alternatives to overcome the limitations of frequent injections and to improve therapeutic outcomes in AMD. This chapter explores the rationale, mechanisms, and current advancements in hydrogel-based platforms and implantable devices designed for the long-term delivery of anti-VEGF agents. We provide a comparative analysis of these two delivery modalities, focusing on their materials, biocompatibility, release kinetics, clinical utility, and translational potential. Furthermore, we discuss the critical role of SR-DDS in supporting personalized medicine through patient-specific dosing strategies and their ability to maintain therapeutic drug levels with minimal invasiveness. Challenges in the development and regulatory approval of SR-DDS, including manufacturing complexity, long-term safety, and economic viability, are also addressed. Finally, we highlight emerging trends in biomaterials science, precision engineering, and combination therapy strategies that may shape the next generation of drug delivery platforms for AMD. Together, these insights underscore the transformative potential of SR-DDS in redefining the clinical management of AMD by offering sustained, localized, and patient-tailored therapeutic delivery.
- 26 July 2025
- Published by Springer Nature
- p. 71-86
Sustained Drug Delivery Systems for Age-Related Macular Degeneration: Advancements, Challenges, and Future Perspectives
Age-related macular degeneration (AMD) is a leading cause of vision loss among the elderly and remains a major public health challenge due to its chronic progression and high recurrence rate. Current standard treatment relies heavily on repeated intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents, which impose significant burdens on patients and healthcare systems. In recent years, sustained-release drug delivery systems (SR-DDS) have emerged as promising alternatives to overcome the limitations of frequent injections and to improve therapeutic outcomes in AMD. This chapter explores the rationale, mechanisms, and current advancements in hydrogel-based platforms and implantable devices designed for the long-term delivery of anti-VEGF agents. We provide a comparative analysis of these two delivery modalities, focusing on their materials, biocompatibility, release kinetics, clinical utility, and translational potential. Furthermore, we discuss the critical role of SR-DDS in supporting personalized medicine through patient-specific dosing strategies and their ability to maintain therapeutic drug levels with minimal invasiveness. Challenges in the development and regulatory approval of SR-DDS, including manufacturing complexity, long-term safety, and economic viability, are also addressed. Finally, we highlight emerging trends in biomaterials science, precision engineering, and combination therapy strategies that may shape the next generation of drug delivery platforms for AMD. Together, these insights underscore the transformative potential of SR-DDS in redefining the clinical management of AMD by offering sustained, localized, and patient-tailored therapeutic delivery.
- Open Access
- 15 July 2025
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 50 (4) , 621-622
Enhancement of chondrogenic differentiation in ATDC5 cells using GFOGER-modified peptide nanofiber scaffold
Article Enhancement of chondrogenic differentiation in ATDC5 cells using GFOGER-modified peptide nanofiber scaffold was published on August 22, 2025 in the journal Turkish Journal of Biochemistry (volume 0, issue 0).
- 15 July 2025
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 50 (4) , 621-622
Open AccessEnhancement of chondrogenic differentiation in ATDC5 cells using GFOGER-modified peptide nanofiber scaffold
Article Enhancement of chondrogenic differentiation in ATDC5 cells using GFOGER-modified peptide nanofiber scaffold was published on August 22, 2025 in the journal Turkish Journal of Biochemistry (volume 0, issue 0).
- 4 July 2025
- Published by Springer Nature in Current Oral Health Reports
- Vol. 12 (1) , 1-14
Translational Advances in Regenerative Dentistry: Functional Biomaterials and Emerging Technologies
- 4 July 2025
- Published by Springer Nature in Current Oral Health Reports
- Vol. 12 (1) , 1-14
Translational Advances in Regenerative Dentistry: Functional Biomaterials and Emerging Technologies